228 related articles for article (PubMed ID: 28455702)
1. Allosteric Inhibition of Serotonin 5-HT
Satała G; Duszyńska B; Lenda T; Nowak G; Bojarski AJ
Mol Neurobiol; 2018 Apr; 55(4):2897-2910. PubMed ID: 28455702
[TBL] [Abstract][Full Text] [Related]
2. The atypical antipsychotics clozapine and olanzapine promote down-regulation and display functional selectivity at human 5-HT7 receptors.
Andressen KW; Manfra O; Brevik CH; Ulsund AH; Vanhoenacker P; Levy FO; Krobert KA
Br J Pharmacol; 2015 Aug; 172(15):3846-60. PubMed ID: 25884989
[TBL] [Abstract][Full Text] [Related]
3. Differential inverse agonist efficacies of SB-258719, SB-258741 and SB-269970 at human recombinant serotonin 5-HT7 receptors.
Mahé C; Loetscher E; Feuerbach D; Müller W; Seiler MP; Schoeffter P
Eur J Pharmacol; 2004 Jul; 495(2-3):97-102. PubMed ID: 15249157
[TBL] [Abstract][Full Text] [Related]
4. Functional characterisation of the human cloned 5-HT7 receptor (long form); antagonist profile of SB-258719.
Thomas DR; Gittins SA; Collin LL; Middlemiss DN; Riley G; Hagan J; Gloger I; Ellis CE; Forbes IT; Brown AM
Br J Pharmacol; 1998 Jul; 124(6):1300-6. PubMed ID: 9720804
[TBL] [Abstract][Full Text] [Related]
5. Decreased agonist, but not antagonist, binding to the naturally occurring Thr92Lys variant of the h5-HT7(a) receptor.
Brüss M; Kiel S; Bönisch H; Kostanian A; Göthert M
Neurochem Int; 2005 Aug; 47(3):196-203. PubMed ID: 15896881
[TBL] [Abstract][Full Text] [Related]
6. Allosteric modulation of 5-HT(1A) receptors by zinc: Binding studies.
Barrondo S; Sallés J
Neuropharmacology; 2009 Feb; 56(2):455-62. PubMed ID: 18951909
[TBL] [Abstract][Full Text] [Related]
7. Reanalysis of constitutively active rat and human 5-HT7(a) receptors in HEK-293F cells demonstrates lack of silent properties for reported neutral antagonists.
Romero G; Pujol M; Pauwels PJ
Naunyn Schmiedebergs Arch Pharmacol; 2006 Oct; 374(1):31-9. PubMed ID: 16967291
[TBL] [Abstract][Full Text] [Related]
8. Heterologous desensitization is evoked by both agonist and antagonist stimulation of the human 5-HT(7) serotonin receptor.
Krobert KA; Andressen KW; Levy FO
Eur J Pharmacol; 2006 Feb; 532(1-2):1-10. PubMed ID: 16487959
[TBL] [Abstract][Full Text] [Related]
9. Allosteric regulation by oleamide of the binding properties of 5-hydroxytryptamine7 receptors.
Hedlund PB; Carson MJ; Sutcliffe JG; Thomas EA
Biochem Pharmacol; 1999 Dec; 58(11):1807-13. PubMed ID: 10571256
[TBL] [Abstract][Full Text] [Related]
10. [3H]-Mesulergine labels 5-HT7 sites in rat brain and guinea-pig ileum but not rat jejunum.
Hemedah M; Coupar IM; Mitchelson FJ
Br J Pharmacol; 1999 Jan; 126(1):179-88. PubMed ID: 10051134
[TBL] [Abstract][Full Text] [Related]
11. Serotonin 5-HT7 receptors coupled to induction of interleukin-6 in human microglial MC-3 cells.
Mahé C; Loetscher E; Dev KK; Bobirnac I; Otten U; Schoeffter P
Neuropharmacology; 2005 Jul; 49(1):40-7. PubMed ID: 15992579
[TBL] [Abstract][Full Text] [Related]
12. The arylpiperazine derivatives N-(4-cyanophenylmethyl)-4-(2-diphenyl)-1-piperazinehexanamide and N-benzyl-4-(2-diphenyl)-1-piperazinehexanamide exert a long-lasting inhibition of human serotonin 5-HT7 receptor binding and cAMP signaling.
Atanes P; Lacivita E; Rodríguez J; Brea J; Burgueño J; Vela JM; Cadavid MI; Loza MI; Leopoldo M; Castro M
Pharmacol Res Perspect; 2013 Dec; 1(2):e00013. PubMed ID: 25505568
[TBL] [Abstract][Full Text] [Related]
13. Serotonin (5-HT7) receptor-stimulated activation of cAMP-PKA pathway in bovine corneal epithelial and endothelial cells.
Grueb M; Rohrbach JM; Schlote T; Mielke J
Ophthalmic Res; 2012; 48(1):22-7. PubMed ID: 22222787
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization of the recombinant human 5-hydroxytryptamine7(a) receptor isoform coupled to adenylate cyclase stimulation.
Adham N; Zgombick JM; Bard J; Branchek TA
J Pharmacol Exp Ther; 1998 Nov; 287(2):508-14. PubMed ID: 9808674
[TBL] [Abstract][Full Text] [Related]
15. 5-HT7 receptors as a new target for prostate cancer physiopathology and treatment: an experimental study on PC-3 cells and FFPE tissues.
Cinar I; Sirin B; Halici Z; Palabiyik-Yucelik SS; Akpinar E; Cadirci E
Naunyn Schmiedebergs Arch Pharmacol; 2021 Jun; 394(6):1205-1213. PubMed ID: 33528589
[TBL] [Abstract][Full Text] [Related]
16. Characterization of putative 5-HT7 receptors mediating tachycardia in the cat.
Villalón CM; Heiligers JP; Centurión D; De Vries P; Saxena PR
Br J Pharmacol; 1997 Jul; 121(6):1187-95. PubMed ID: 9249256
[TBL] [Abstract][Full Text] [Related]
17. The constitutive activity of melanocortin-4 receptors in cAMP pathway is allosterically modulated by zinc and copper ions.
Link R; Veiksina S; Tahk MJ; Laasfeld T; Paiste P; Kopanchuk S; Rinken A
J Neurochem; 2020 May; 153(3):346-361. PubMed ID: 31792980
[TBL] [Abstract][Full Text] [Related]
18. Molecular pharmacological differences in the interaction of serotonin with 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors.
Leonhardt S; Gorospe E; Hoffman BJ; Teitler M
Mol Pharmacol; 1992 Aug; 42(2):328-35. PubMed ID: 1355262
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of 5-HT7 Serotonin Receptors by the Atypical Antipsychotics Clozapine and Olanzapine. Role of Motifs in the C-Terminal Domain and Interaction with GASP-1.
Manfra O; Van Craenenbroeck K; Skieterska K; Frimurer T; Schwartz TW; Levy FO; Andressen KW
ACS Chem Neurosci; 2015 Jul; 6(7):1206-18. PubMed ID: 25706089
[TBL] [Abstract][Full Text] [Related]
20. Clozapine and other competitive antagonists reactivate risperidone-inactivated h5-HT7 receptors: radioligand binding and functional evidence for GPCR homodimer protomer interactions.
Teitler M; Toohey N; Knight JA; Klein MT; Smith C
Psychopharmacology (Berl); 2010 Dec; 212(4):687-97. PubMed ID: 20827463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
